Target intelligence / Profile preview

Neuromotor system

Molecular classification
Other
01

Overview

The **neuromotor system** refers to the integrated network of neurons and muscles responsible for the initiation, coordination, and execution of voluntary movements. It encompasses both upper and lower motor neurons as well as their connections with skeletal muscle fibers. The neuromotor system is not a single molecule or receptor but rather a complex physiological network that includes various cell types (such as motor neurons), molecular motors (like kinesin, dynein, myosin), synaptic components, and signaling pathways[1][2][3]. Dysfunction in this system can lead to diseases such as spinal muscular atrophy or amyotrophic lateral sclerosis[3]. Because it is not a discrete molecular entity but an entire functional network or anatomical/physiological concept, it does not fit the definition of a therapeutic target like a receptor or enzyme. Key points supporting "is_incorrect": The term "neuromotor system" describes an entire biological network/system rather than a specific molecule or druggable target. There are no canonical abbreviations; it is generally referred to by its full name. No direct interacting drugs exist for the "system" itself—therapeutic interventions typically target specific components within this broader framework (e.g., individual receptors on motor neurons)[1][2][3].

Other names
Motor systemSensory-motor systemMotor neuron system
02

Biological functions

Control of voluntary movementCoordination of muscle contractionSignal transduction between nervous system and muscles
03

Disease associations

Neurodegenerative diseaseMotor neuron disease (e.g., Amyotrophic lateral sclerosis)Spinal muscular atrophyOther neurological disorders

Beyond the preview

Go deeper on Neuromotor system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuromotor system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call